Entrepreneur UK's London 100: Amilis Amilis bridges the gender data gap with AI-driven reproductive health insights and real-world patient-doctor data
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media.
Industry: Healthtech
Sixth place on Entrepreneur UK's London100 list is Amilis.
"We're not just helping women track their reproductive health," says Sarita Stefani, CEO of Amilis, "we're fixing a broken healthcare system by creating the dataset that's been missing all along. Amilis is the first platform to structure real-world data from both patients and doctors, finally giving women the care and answers they've always deserved."
Amilis is an AI-powered doctor platform and patient app generating the first sex-specific real-world dataset in women's health, addressing a global problem: most healthcare data is still based on male physiology, leaving women undiagnosed, under-treated, and unheard.
The company has been selected for the Plug and Play Health Accelerator, a global innovation platform and venture capital firm, and for Female Founders Rise, a community that empowers female and non-binary entrepreneurs with resources, coaching, and networking.
They are currently raising their next round of funding and preparing to launch in Europe in 2025.
What sets Amilis apart is that they don't just digitise care — they generate high-value, sex-specific data that life sciences companies desperately need to design better drugs, run more inclusive clinical trials, and finally close the gender data gap in medicine.
Since launching, Amilis has:
- Onboarded 42 paying doctors, with 15 actively using the platform.
- Signed contracts with 8 fertility clinics and HCA Healthcare, the world's largest private hospital group.
- Completed a pilot with Ferring Pharmaceuticals and secured LOIs from multiple global pharma companies to access their dataset.
- Maintained 86% retention on their beta-tested patient app.
- Completed over 2,000 diagnostics and treatments via the platform.
